Pro-Dex Inc. (PDEX) exhibits 29.3% gross margins and 23.2% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 16.5x enterprise multiple and 4.8% implied options volatility.
Sustained 29.3% gross profitability converts into 16.1% operating margin and 23.2% ROIC, outpacing sector cost of capital.
ROIC: 23.2% // GM: 29.3%YoY revenue trajectory of +23.7% paired with -1.47% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +23.7% // FCF YLD: -1.47%Altman Z-Score of 9.08 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 9.08 // F-SCORE: 5/9Trading at 22.2x trailing P/E (18.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 22.2x // EV/EBITDA: 16.5xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $61.60 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 13.5% net margins.
NET MARGIN: 13.5% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for PDEX & activate live FRED threshold breach alerts.